Melphalan and whole-blood stem cell reinfusion in castration-resistant prostate cancer (CRPC): A phase I/II study.
J. Shamash
Research Funding - Chugai Pharma
J. Jacob
No relevant relationships to disclose
T. Powles
No relevant relationships to disclose
S. Agrawal
Research Funding - Chugai Pharma
K. Mutsvangwa
No relevant relationships to disclose
N. Saunders
No relevant relationships to disclose
P. Wilson
No relevant relationships to disclose
J. Stebbing
No relevant relationships to disclose